For many patients with blood cancers like leukaemia s, lymphomas & Thalassemia; Bone marrow transplantation is a life-saving therapy. Medical oncologist follows the standard blood-generating stem ...
San Diego, California; London, UK and Bergisch Gladbach, Germany, December 18, 2023 – Replay, a genome writing company reprogramming biology by writing, designing and delivering big DNA, and Miltenyi ...
IsoPlexis, which recently received an NCI grant, reports that it has published a technology note with Miltenyi Biotec in a co-marketing agreement. The tech note (“Getting the most out of your CAR-T ...
Regenerative medicine has become a key focus worldwide and the number of stem cell-based clinical trials are rapidly increasing every year. Yet, large-scale and GMP-compliant stem cell manufacturing ...
Regenerative medicine has become a key focus worldwide and the number of stem cell, especially pluripotent stem cell (PSC)-based clinical trials are rapidly increasing every year. Yet, large-scale and ...
The CliniMACS Prodigy, a device designed to manufacture cellular products used in cell-based therapies. Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact ...
Some of the most cutting-edge approaches to treating cancer over the past decade arose from personalized immunotherapy. Chimeric antigen receptor (CAR) T cells can be engineered to specifically target ...
Miltenyi Biotec opens first office and Technology Center in Hyderabad, India, focusing on Cell and Gene Therapy (CGT). The Center offers training, research, and manufacturing solutions for CGT, using ...
Hyderabad: Miltenyi Biotec, a global leader in cell and gene therapy (CGT) solutions, has launched India's first dedicated Cell & Gene Therapy Center of Excellence (CoE) in Hyderabad. Located in ...
Syena secures exclusive license to Miltenyi Biotec’s PRAME TCR Syena, co-founded by Replay and MD Anderson in 2023, will develop an off-the-shelf PRAME TCR-NK cell therapy, with IND anticipated Q1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results